150 Mg Tucatinib Tablets

Name: 150 Mg Tucatinib Tablets
Brand: NEETCO BIOPHARMA
Price: 30000 INR
Availability: InStock

Price 30000 INR/ Bottle

Get a Price/Quote

MOQ : 1 Bottle

150 Mg Tucatinib Tablets Specification

Salt Composition
Tucatinib 150 mg

Dosage Form
Tablet

Indication
HER2-positive metastatic breast cancer

Feature
Targeted therapy, convenient oral administration

Ingredients
Tucatinib, excipients

Application
Oral anti-cancer therapy

Physical Color/Texture
Yellow, film-coated tablet

Fermentation Smell
Odorless

Storage Instructions
Store below 30C, protect from moisture

Shelf Life
24 Months

Marketed By
As per label

Trade Name
Tucatinib 150 mg Tablets

Prescription Status
Prescription only

Packaging
30 tablets per bottle

Route of Administration
Oral

Strength
150 mg

About 150 Mg Tucatinib Tablets

Presenting Tucatinib 150 mg Tablets-an impeccable solution for patients diagnosed with HER2-positive metastatic breast cancer. Take advantage of our limited time promotion, offering top-drawer, targeted oral therapy in each bottle containing 30 film-coated, yellow tablets. With an unassailable reputation for efficacy, these prescription-only tablets combine Tucatinib and select excipients for a trusted treatment approach. Shelf life extends to 24 months, guaranteeing reliable quality. Stored below 30C, protected from moisture, this product is distributed, exported, and supplied throughout India. Don't miss this exclusive offer-order today!

Applications and Features of Tucatinib 150 mg Tablets

Tucatinib 150 mg Tablets are utilized in the treatment of HER2-positive metastatic breast cancer, providing targeted therapy with unassailable precision. As a convenient oral anti-cancer therapy, the top-drawer formulation ensures efficient drug delivery. Ideal for use in hospitals, clinics, and by oncologists specializing in breast cancer treatment, these tablets feature impeccable film-coating for optimal stability and a professional finish. Their odorless nature and yellow color further distinguish their superior quality.

Sample Availability, Packaging, and Purchase Process

Sample bottles of Tucatinib 150 mg Tablets are available upon request. Each bottle contains 30 tablets, packaged securely for integrity during transit. Subject to our sample policy, dispatching will occur promptly once a valid purchase order is placed and rates are agreed upon. Our streamlined process helps ensure rapid delivery, giving distributors and healthcare professionals the assurance of timely access to high-quality products. Contact us to inquire about sample provision and distribution rates.

FAQ's of 150 Mg Tucatinib Tablets:

Q: How are Tucatinib 150 mg Tablets administered for therapy?

A: Tucatinib 150 mg Tablets are administered orally, typically as part of a prescribed treatment regimen for HER2-positive metastatic breast cancer. Patients should follow their healthcare professional's instructions carefully for optimal results.

Q: What is the strength and packaging detail for Tucatinib 150 mg Tablets?

A: Each tablet contains 150 mg of Tucatinib, with 30 yellow, film-coated tablets provided per bottle. This ensures a convenient supply for ongoing therapy as directed by medical personnel.

Q: When should Tucatinib 150 mg Tablets be prescribed?

A: Tucatinib 150 mg Tablets are prescribed for individuals diagnosed with HER2-positive metastatic breast cancer, particularly when targeted therapy is recommended by oncologists as part of their treatment plan.

Q: Where can these tablets be used or obtained?

A: Tucatinib 150 mg Tablets are available through authorized distributors, exporters, suppliers, and traders in India. Medical facilities such as hospitals and cancer clinics are the primary application places.

Q: What process should I follow to request a sample or place an order?

A: To request a sample, provide a standard purchase order specifying the rate and desired quantity. Dispatching will be initiated as per your confirmed order and our sample policy.

Q: What are the key benefits of Tucatinib 150 mg Tablets?

A: These tablets offer targeted therapy with high effectiveness against HER2-positive metastatic breast cancer. Their impeccable formulation, convenient oral administration, and long shelf life add significant value to patient care.

Tell us about your requirement